first glp 1 GLP-1 receptor agonists The GLP-1 journey: from discovery

Clinical trials have explored the safety profile of AOD and reported few adverse effects, such as insulin resistance or unwanted muscle growth, which are typically associated with traditional GH therapies (2)

Recomposition preserves the structural integrity of the body, including the face and other areas prone to volume loss, because lean muscle tissue signals the body to maintain protein synthesis and tissue repair rather than breaking down structural compartments for fuel

If bruising persists or worsens, check in with your licensed provider

Neither medicine is currently licensed in the UK, but early clinical trial data are promising

Co-authors include Dr